Journal article
A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience
Abstract
PURPOSE: Obstructive symptoms that affect quality of life (QOL) are commonly caused by endobronchial disease in many patients with locally advanced, inoperable lung cancer. High-dose-rate endobronchial brachytherapy (HDREBBT) has been used to palliate these symptoms, yet its role is not well defined in the literature.
METHODS AND MATERIALS: Ninety-eight patients with locally advanced, inoperable lung cancer received HDREBBT. They were …
Authors
Goldberg M; Timotin E; Farrell T; Puksa S; Donde B; Sur R
Journal
Brachytherapy, Vol. 14, No. 5, pp. 655–661
Publisher
Elsevier
Publication Date
September 2015
DOI
10.1016/j.brachy.2015.04.005
ISSN
1538-4721